The National Institute on Drug Abuse (NIDA) is offering a grant to support collaborative research in advancing compounds towards FDA approval for treating Substance Use Disorders. This grant encourages strategic alliances with external organizations to expedite the drug development process. Single entities with substantial resources can also apply, provided a significant commitment to the project is demonstrated. Projects should aim to accelerate medications development for SUDs, with defined entry and exit points in the development pathway. The grant period and budget are designed to hasten the pace of research compared to traditional funding, ultimately leading to improved treatments for SUDs. Closing date for applications is July 25, 2019.
Opportunity ID: 298906
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-218 |
| Funding Opportunity Title: | Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 21, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 25, 2019 |
| Current Closing Date for Applications: | Jul 25, 2019 |
| Archive Date: | Aug 30, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $3,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Private institutions of higher education Native American tribal governments (Federally recognized) County governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Small businesses State governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support research that advances compounds towards FDA approval by leveraging NIDA funds with the strengths and resources of outside organizations, such as for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, and small businesses. Applications from single entities that possess considerable resources for medications development will also be considered, provided the entity demonstrates a significant resource commitment to the proposed project. A resource commitment from a single entity could, for example, consist of salary support for key personnel or production and formulation of clinical trial material. It is anticipated that in comparison with traditional grant-funded research, strategic alliances will increase the pace at which medications to treat Substance Use Disorders (SUDs) move through the drug development process. Both the project period and budget of the grant are consistent with the objective of accelerating the pace of medications development compared to traditional research project grant funding. Project aims can range from the development of a new molecular entity to the expansion of an existing medications clinical indication(s). Each project should have a defined entry and exit point in the medications development pathway, with the objective of advancement in the FDA approval process. It is hoped that support for these collaborations will accelerate the rate of medications development for SUDs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-218.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236470 | Feb 25, 2018 | Jul 25, 2019 | View |
Package 1
Mandatory forms
298906 RR_SF424_2_0-2.0.pdf
298906 PHS398_CoverPageSupplement_4_0-4.0.pdf
298906 RR_OtherProjectInfo_1_4-1.4.pdf
298906 PerformanceSite_2_0-2.0.pdf
298906 RR_KeyPersonExpanded_2_0-2.0.pdf
298906 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298906 RR_Budget_1_4-1.4.pdf
298906 RR_SubawardBudget30_1_4-1.4.pdf
298906 PHS398_ModularBudget_1_2-1.2.pdf
298906 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
